Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Cancer Medicine
|
September 18, 2015
B7-H3 protein expression in acute myeloid leukemia
Thomas Guery, Christophe Roumier, Celine Berthon, et al.
Leukemia Research Reports
|
May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
Celine Berthon, Morgane Nudel, Eileen M Boyle, et al.
Leukemia Research
|
May 28, 2022
Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents
Paul Chauvet, Olivier Nibourel, Celine Berthon, et al.
Leukemia & Lymphoma
|
December 29, 2004
Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma
Stephane Depil, Xavier Leleu, Jean-Baptiste Micol, et al.
Cancers
|
December 24, 2021
Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients
Quentin Fovez, William Laine, Laure Goursaud, et al.
American Journal of Hematology
|
November 11, 2011
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association
Hassan Farhat, Oumedaly Reman, Emmanuel Raffoux, et al.
Leukemia Research
|
May 3, 2005
Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival
Xavier Leleu, Franck Genevieve, Romain Guieze, et al.
Blood Advances
|
October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Juliette Lambert, Jerome Lambert, Xavier Thomas, et al.
Blood
|
March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML
Margaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 13, 2021
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group
Mauricette Michallet, Mohamad Sobh, Stephane Morisset, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Cancer Medicine
|
September 18, 2015
B7-H3 protein expression in acute myeloid leukemia
Thomas Guery, Christophe Roumier, Celine Berthon, et al.
Leukemia Research Reports
|
May 7, 2020
Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size
Celine Berthon, Morgane Nudel, Eileen M Boyle, et al.
Leukemia Research
|
May 28, 2022
Resurgence of myeloproliferative neoplasm in patients in remission from blast transformation after treatment with hypomethylating agents
Paul Chauvet, Olivier Nibourel, Celine Berthon, et al.
Leukemia & Lymphoma
|
December 29, 2004
Abnormal cytogenetics and significant bone marrow plasmacytosis are predictive of early progression and short survival in patients with low tumor mass asymptomatic multiple myeloma
Stephane Depil, Xavier Leleu, Jean-Baptiste Micol, et al.
Cancers
|
December 24, 2021
Clinically Relevant Oxygraphic Assay to Assess Mitochondrial Energy Metabolism in Acute Myeloid Leukemia Patients
Quentin Fovez, William Laine, Laure Goursaud, et al.
American Journal of Hematology
|
November 11, 2011
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association
Hassan Farhat, Oumedaly Reman, Emmanuel Raffoux, et al.
Leukemia Research
|
May 3, 2005
Irregular nuclear shape of bone marrow plasma cells defines a multiple myeloma subgroup related to hypodiploidy and to short survival
Xavier Leleu, Franck Genevieve, Romain Guieze, et al.
Blood Advances
|
October 9, 2021
Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
Juliette Lambert, Jerome Lambert, Xavier Thomas, et al.
Blood
|
March 10, 2021
Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML
Margaux Sevin, Franck Debeurme, Lucie Laplane, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 13, 2021
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group
Mauricette Michallet, Mohamad Sobh, Stephane Morisset, et al.
Page
of 2